NM_130768.3:c.662T>C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_130768.3(ASZ1):​c.662T>C​(p.Ile221Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000471 in 1,611,986 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000039 ( 1 hom. )

Consequence

ASZ1
NM_130768.3 missense

Scores

12
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.72

Publications

0 publications found
Variant links:
Genes affected
ASZ1 (HGNC:1350): (ankyrin repeat, SAM and basic leucine zipper domain containing 1) Predicted to be involved in gamete generation and piRNA metabolic process. Predicted to be located in cytoplasm. Predicted to be active in pi-body. [provided by Alliance of Genome Resources, Apr 2022]
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
CFTR Gene-Disease associations (from GenCC):
  • cystic fibrosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
  • congenital bilateral absence of vas deferens
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary chronic pancreatitis
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASZ1NM_130768.3 linkc.662T>C p.Ile221Thr missense_variant Exon 6 of 13 ENST00000284629.7 NP_570124.1 Q8WWH4-1
ASZ1NM_001301821.2 linkc.662T>C p.Ile221Thr missense_variant Exon 6 of 13 NP_001288750.1 Q8WWH4-2
ASZ1NM_001301822.2 linkc.38T>C p.Ile13Thr missense_variant Exon 5 of 12 NP_001288751.1 Q8WWH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASZ1ENST00000284629.7 linkc.662T>C p.Ile221Thr missense_variant Exon 6 of 13 1 NM_130768.3 ENSP00000284629.2 Q8WWH4-1

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152152
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000763
AC:
19
AN:
249014
AF XY:
0.0000594
show subpopulations
Gnomad AFR exome
AF:
0.0000620
Gnomad AMR exome
AF:
0.000321
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000551
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000890
Gnomad OTH exome
AF:
0.000662
GnomAD4 exome
AF:
0.0000390
AC:
57
AN:
1459834
Hom.:
1
Cov.:
30
AF XY:
0.0000358
AC XY:
26
AN XY:
726238
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33306
American (AMR)
AF:
0.000450
AC:
20
AN:
44406
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26084
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39458
South Asian (SAS)
AF:
0.0000929
AC:
8
AN:
86074
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53356
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.0000180
AC:
20
AN:
1111116
Other (OTH)
AF:
0.000149
AC:
9
AN:
60284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152152
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41434
American (AMR)
AF:
0.00105
AC:
16
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000503
Hom.:
0
Bravo
AF:
0.000302
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.662T>C (p.I221T) alteration is located in exon 6 (coding exon 6) of the ASZ1 gene. This alteration results from a T to C substitution at nucleotide position 662, causing the isoleucine (I) at amino acid position 221 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.066
T
BayesDel_noAF
Uncertain
-0.030
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.35
T
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.85
D
M_CAP
Benign
0.068
D
MetaRNN
Uncertain
0.50
T
MetaSVM
Benign
-0.47
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
6.7
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-3.2
D
REVEL
Uncertain
0.49
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.036
D
Polyphen
0.95
P
Vest4
0.78
MutPred
0.38
Gain of phosphorylation at I221 (P = 0.031);
MVP
0.73
MPC
0.088
ClinPred
0.12
T
GERP RS
4.7
Varity_R
0.35
gMVP
0.33
Mutation Taster
=52/48
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780891217; hg19: chr7-117024805; API